Results 261 to 270 of about 6,083,333 (340)
ABSTRACT Background Poststroke fatigue (PSF) and frailty share substantial overlap in their manifestations, yet previous research has yielded conflicting results due to the use of heterogeneous frailty assessment tools. Objective To evaluate the independent impact of frailty on PSF using a unified measurement system (Tilburg Frailty Indicator, TFI ...
Chuan‐Bang Chen +6 more
wiley +1 more source
Integration of pharmacists into primary care teams for high-risk Medicare patients. [PDF]
Winter FD.
europepmc +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source
Correction to Supporting Information for Han et al., CASKIN2 mediates PTPσ-orchestrated transsynaptic mechanisms at excitatory synapses. [PDF]
europepmc +1 more source
SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights
ABSTRACT Objective SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.
Nuria Muelas +18 more
wiley +1 more source
Bridging the Gap: Identifying and Overcoming Barriers to CAR-T Access Through Streamlined and Standardized Pathways. [PDF]
Uttam Chandani K, Khera N.
europepmc +1 more source
2014 SICPRE Proceedings: Meeting Proceedings.
openaire +1 more source
Correction for He et al., GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex. [PDF]
europepmc +1 more source

